As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock – Investorplace.com
As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock Investorplace.com AbbVie is doing all it can to keep Humira sales high, but competition and regulation mean the party could be ending for AbbVie stock.